Methylated circulating tumor DNA as a potential marker of PARP inhibitor efficiency in BRCA mutated ovarian cancer patients.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

OriginalsprogDansk
Publikationsdato4. jun. 2018
StatusUdgivet - 4. jun. 2018
Begivenhed2018 ASCO Annual Meeting: Delivering discoveries: Expanding the reach of precision medicine - McCormick Place, Chicago , USA
Varighed: 1. jun. 20185. jun. 2018
https://am.asco.org

Konference

Konference2018 ASCO Annual Meeting
LokationMcCormick Place
LandUSA
ByChicago
Periode01/06/201805/06/2018
Internetadresse

Bibliografisk note

J Clin Oncol 36, 2018 (suppl; abstr 5540)

Citationsformater